The National Multiple Sclerosis Society and others announce MS research and training funding opportunities

The Society is pleased to highlight a number of new funding opportunities aimed to bolster MS research and training.

2025-06-05

(Press-News.org) As the largest MS organization in the world and a global leader of the MS movement, the National Multiple Sclerosis Society is committed to supporting research and career development that will accelerate breakthroughs in understanding, treating, and ultimately curing MS. The Society is pleased to highlight a number of new funding opportunities aimed to bolster MS research and training. Support originates both from the Society and outside entities.

Awards are summarized below along with individual links to learn more about the details of each award, eligibility, and application instructions.

The National MS Society is offering funding opportunities that invest in the next generation of MS researchers and clinicians, and support projects focused on advancing women’s health in MS:

Building a workforce of highly trained scientists and clinicians is crucial to finding cures for MS. Offered annually, advanced training fellowships and early-career awards are now accepting applications from MS researchers and physicians. The opportunities differ in duration (ranging from one to five years) and scope (covering both basic science and clinical research). Applications are also being accepted for awards to train board eligible/certified neurologists or physiatrists in specialized MS clinical care. All opportunities are designed to invest in emerging talent to build the skills needed to optimize clinical care and drive future breakthroughs in MS. Pre-applications are due August 6, 2025 (clinical care) and August 13, 2025 (fellowships). When Society staff identify gaps in the Pathways to Cures Research Roadmap, targeted funding opportunities are created to increase awareness and research in those specific areas. The Society recently highlighted priority research areas related to women’s health in MS that remain largely unexplored. In response, the Society is requesting grant applications for proposed research that addresses the knowledge gaps in women’s health issues for people with MS. Pre-applications are due August 20, 2025. The American Brain Foundation, with support from the National MS Society and other organizations, is soliciting applications for Breakthrough Grants and Catalyst Grants as part of the 2025 Cure One, Cure Many Award in Neuroinflammation:

A total of at least $5.4M is available through this call. Two Breakthrough Grants of up to $2M each and at least two Catalyst Grants of up to $500k each are available for research proposals in Neuroinflammation. Breakthrough Grants are designed to support interdisciplinary teams investigating novel neuroinflammation mechanisms and the potential development of new biomarkers, therapeutic targets, or technologies. Catalyst Grants are intended to help researchers overcome critical research hurdles and offer flexibility to explore bold ideas that have the potential to lead to significant advances in diagnosis, treatment, or prevention. Details are available in the full Request for Applications or by visiting the American Brain Foundation website. Pre-proposals are due July 15, 2025. The United States Department of Defense’s Peer Reviewed Medical Research Program (PRMRP) is accepting applications for its FY25 Technology/Therapeutic Development Award and Clinical Trial Award:

The Technology/Therapeutic Development Award is a product-driven award intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, for a disease or condition related to one of the FY25 PRMRP topic areas, which includes multiple sclerosis. Pre-applications are due June 9, 2025. The Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of a disease or condition addressed in one of the congressionally directed FY25 PRMRP topic areas, which includes multiple sclerosis. Pre-applications are due June 9, 2025. END

ELSE PRESS RELEASES FROM THIS DATE:

China successfully develops its first double-spoke superconducting cavity cryomodule

2025-06-05

Designed a high-performance double-spoke superconducting cavity. The research team implemented comprehensive electromagnetic and mechanical optimizations on the double-spoke superconducting cavity, achieving three key improvements: reduction of peak electric field during normal operation, suppression of multipacting effects, and enhanced manufacturability. A dedicated Buffered Chemical Polishing tooling system was developed for double-spoke superconducting cavities with complex structures, ensuring uniform acid etching and achieving high Q-values (Q > 3.4×10¹⁰ @ Eₐcc = 9 MV/m). Developed a high-performance cryomodule The ...

Study helps pinpoint areas where microplastics will accumulate

2025-06-05

The accumulation of microplastics in the environment, and within our bodies, is an increasingly worrisome issue. But predicting where these ubiquitous particles will accumulate, and therefore where remediation efforts should be focused, has been difficult because of the many factors that contribute to their dispersal and deposition. New research from MIT shows that one key factor in determining where microparticles are likely to build up has to do with the presence of biofilms. These thin, sticky biopolymer layers are shed by microorganisms and can accumulate ...

NRG Oncology study shows the addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence in patients whose axillary nodes convert from positive to negative foll

2025-06-05

Recent results from the NRG-NSABP B-51/RTOG 1304 clinical study showed that the addition of regional nodal irradiation (RNI) does not decrease the rates of invasive breast cancer recurrence in patients whose positive axillary nodes at presentation convert to negative following neoadjuvant chemotherapy. These results were recently published in the New England Journal of Medicine. The study enrolled 1,641 patients stratified by type of surgery (mastectomy, lumpectomy), hormone receptor status (ER-positive and/or PgR-positive; ER- and PgR-negative), HER2 status, adjuvant chemotherapy use, and pathologic complete response (pCR) in the breast, then randomized to RNI vs. ...

Cancer treatments should be licensed for all ages, oncologists say

2025-06-05

Recent advances have resulted in highly effective “tissue-agnostic” drugs that treat cancers based on their molecular markers rather than their tissue of origin, but very few of these drugs are approved for use in children. In an opinion paper publishing June 5 in the Cell Press journal Trends in Cancer, oncologists call for “ag(e)nostic” cancer treatments: drugs that are both tissue agnostic and approved for cancer patients of all ages. “Cancer treatment in children is a huge unmet need. These drugs are extremely effective, and we want to see children have access to them,” says senior author Razelle ...

US self-reported race and ethnicity are poor proxies of genetic ancestry

2025-06-05

Genetic ancestry is much more complicated than how people report their race and ethnicity. New research, using data from the National Institutes of Health’s (NIH) All of Us Research Program, finds that people who identify as being from the same race or ethnic group can have a wide range of genetic differences. The findings are reported June 5 in the Cell Press journal the American Journal of Human Genetics. As doctors and researchers learn more about how genetic variants influence the incidence and course of human diseases, the study of genetic ancestry has become increasingly important. This research is driving the field of precision medicine, ...

Living towers of worms observed in nature

2025-06-05

Nematodes are the most abundant animal on earth, but when times get tough, these tiny worms have a hard time moving up and out. So, they play to the strength of their clade. If food runs out and competition turns fierce, they slither towards their numerous kin. They climb onto each other and over one another until their bodies forge a living tower that twists skyward where they might hitch a ride on a passing animal to greener and roomier pastures. At least that’s what scientists assumed. For decades, these worm structures ...

New AI transforms radiology with speed, accuracy never seen before

2025-06-05

CHICAGO --- A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology — boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist shortage, a large new study finds. The findings will be published on Thursday (June 5) in JAMA Network Open. “This is, to my knowledge, the first use of AI that demonstrably improves productivity, especially in health care. Even in other fields, I haven’t seen anything close to a 40% boost,” said senior author Dr. Mozziyar Etemadi, an assistant professor of anesthesiology ...

Brain mechanisms that distinguish imagination from reality discovered

2025-06-05

Areas of the brain that help a person differentiate between what is real and what is imaginary have been uncovered in a new study led by UCL researchers. The research, published in Neuron, found that a region in the brain known as the fusiform gyrus – located behind one’s temples, on the underside of the brain’s temporal lobe – is involved in helping the brain to determine whether what we see is from the external world or generated by our imagination. The researchers hope that their findings will increase understanding ...

Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration

2025-06-05

About The Study: In this cohort study, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) among patients with diabetes was associated with a 2-fold higher risk of incident neovascular age-related macular degeneration development than among similar patients with diabetes who did not receive a GLP-1 RA. Further research is needed to elucidate the exact pathophysiological mechanisms involved and to understand the trade-offs between the benefits and risks of GLP-1 RAs. Corresponding Author: To ...

BMI, physical activity, and subsequent neoplasm risk among childhood cancer survivors

2025-06-05

About The Study: Among childhood cancer survivors in this cohort study, obesity was associated with an increased risk for multiple subsequent neoplasm types, while higher physical activity was associated with reduced subsequent neoplasm risk. Lifestyle interventions should be considered in future subsequent neoplasm prevention research. Corresponding Author: To contact the corresponding author, Lenat Joffe, MD, MS, email ljoffe@northwell.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamaoncol.2025.1340) Editor’s Note: Please see the article for additional ...